RD&C is an expert office providing specific in-depth expertise for your pharmaceutical or biotech project



  • Expert statements on impurities
  • Impurity and degradation profiling
  • Evaluation of degradation pathways
  • Expertise in solid state degradation
  • Management of oos events
  • Route cause analysis, CAPAs, etc.
  • in silico mutagenicity assessments
  • Stability by Design


  • Regulatory advice for CMC
  • Expert statements on CMC
  • Preparation of scientific advices (FDA, EMA)
  • DMF, IMPD, CTD module 3
  • FDA compliance of documentation
  • Small molecules, biologics, combination products
  • Environmental Risk Assessment
  • Due Diligences
  • GMP Audits



  • IP strategies
  • Drug discovery
  • Drug development
  • Project management
  • CRO/CMO identification
  • In-depth market knowledge
  • Innovative scientific concepts


  • DR. Helmut Buschmann published with Prof. Ulrike Holzgrabe in DAZ

    Deutsche Apotheke Zeitung | 159. Jahrgang | 10.01.2019 | Nr. 1/2

    - RD&C Team
  • New book “Drug Selectivity” published

    Dr. Helmut Buschmann and Dr. Norbert Handler are co-editors and co-authors of the book "Drug Selectivity - An Evolving Concept in Medicinal Chemistry" published in December 2017

    - RD&C Team
  • Prof. Holzgrabe and Dr. Buschmann published in DAZ

    Prof. Ulrike Holzgrabe (University Wuerzburg) and Helmut Buschmann (RD&C) published a recent article in DAZ on Remifentanil

    - Dr. Helmut Buschmann
  • RD&C as invited speakers for 2-days-workshop “Stability by Design”

    Concept Heidelberg/ECA invited Helmut Buschmann and Norbert Handler to give talks for the workshop "Stability by Design". The 2-day course will be held in Hamburg on April 19th to 20th 2018.

    - RD&C team

    The method could be used for prediction of stability, polymorph changes, shelf-life, degradations in solid environment as well as development tool for solid formulations. The service is offered to customers, but is also open for out-licensing.

    - RD&C Team
  • RD&C GmbH registered the Austrian trade „CONSULTING ENGINEER FOR PHARMACY (Ingenieurbüro für Pharmazie)”.

    The strictly regulated trade "Consulting Engineer" warrants a broad technical expert background with an objective view, directed towards protecting the clients’ interests and ensuring superior performance at the lowest commensurate cost. It includes an expert status in the field ensuring quality, employability and professional recognition.

    - Dr. Norbert Handler
  • Dr. Norbert HANDLER is announced “general authorized and certified expert for pharamceutical chemistry” at the Trade Court of Vienna

    The expert status is announced for 5 years comprises the fields pharmaceutical chemistry, pharmaceutical products and cosmetics.

    - RD&C team

    RD&C team was responsible for Volume 2 "Drug Discovery Technologies". The book is available since June 2017.

    - RD&C team